Magnesium in the treatment of asthma

Current Opinion in Allergy and Clinical Immunology

Volumn 7, Issue 1, 2007, Pages 107-110

  Beasley, Richard ^a   Aldington, Sarah ^a  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

Author keywords

Asthma; Inhaled; Intravenous; Magnesium; Treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MAGNESIUM; MAGNESIUM SULFATE; PLACEBO; SALBUTAMOL; THEOPHYLLINE;

ASTHMA; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; CLINICAL RESEARCH; COCHRANE LIBRARY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

ASTHMA; HUMANS; MAGNESIUM; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 33846210348     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328012ce4b     Document Type: Review

References (37)

1. Trendelenberg F. Physiologische und pharmakologische untersuchungen an der isolierten bronchialmuskulatur. Arch Exp Pharmacol Ther 1912; 19:79-107.
2. Rosello JC, Pla JC. Sulfato de magnesio en la crisis de asma. Prensa Med Argent 1936; 23:1677-1680.
3. Haury VG. Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulphate. J Lab Clin Med 1940; 26:340-341.
4. Rolla G, Bucca C, Arossa W, Bugiani M. Magnesium attenuates methacholine-induced bronchoconstriction in asthmatics. Magnesium 1987; 6940:201-204.
5. Rolla G, Bucca C, Caria E. Dose-related effect of inhaled magnesium sulphate on histamine bronchial challenge in asthmatics. Drugs Exp Clin Res 1988; 14:609-612.
6. Hill J, Lewis S, Britton J. Studies of inhaled magnesium on airway reactivity to histamine and adenosine monophosphate in asthmatic subjects. Clin Exp Allergy 1997; 27:546-551.
7. Hill J, Britton J. Dose-response relationship and time-course of the effect of inhaled magnesium sulphate on airflow in normal and asthmatic subjects. Br J Clin Pharmacol 1995; 40:539-544.
8. Okayama H, Aikawa T, Okayama H, et al. Bronchodilating effects of intravenous magnesium sulfate in bronchial asthma. JAMA 1987; 257:1076-1078.
9. Skobeloff EM, Spivey WH, McNamara RM, Greenspon L. Intravenous magnesium sulphate for the treatment of acute asthma in the emergency department. JAMA 1989; 262:1210-1213.
10. Rolla G, Bucca C, Brussino L, Colagrande P. Effect of intravenous magnesium infusion on salbutamol-induced bronchodilatation in patients with asthma. Magnes Res 1994; 7:129-133.
11. Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulphate as an adjunct in the treatment of acute asthma. Chest 1995; 107:1576-1581.
12. Devi PR, Kumar L, Singhi SC, et al. Intravenous magnesium sulphate in acute severe asthma not responding to conventional therapy. Indian Pediatr 1997; 34:389-397.
13. Silverman R, Osborne H, Runge J, et al. Magnesium sulphate as an adjunct to standard therapy in acute severe asthma. Acad Emerg Med 1996; 3:467-468.
14. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000; 154:979-983.
15. Silverman RA, Osbord H, Runge J, et al. IV magnesium sulphate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest 2002; 122:489-497.
16. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulphate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; (2):CD001490.
17. Mahajan P, Haritos D, Rosenberg N, Thomas R. Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma. J Emerg Med 2004; 27:21-25.
18. Nannini LJ Jr, Pendino JC, Corna RA, et al. Magnesium sulphate as a vehicle for nebulized salbutamol in acute asthma. Am J Med 2000; 108:193-197.
19. Bessmertny O, DiGregorio RV, Cohen H, et al. A randomized clinical trial of nebulized magnesium sulfate in addition to Albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults. Ann Emerg Med 2002; 39:585-591.
20. Hughes R, Goldkorn A, Masoli M, et al. Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in the treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet 2003; 361:2114-2117.
21. Spivey WH, Skobeloff EM, Levin RM. Effect of magnesium chloride on rabbit bronchial smooth muscle. Ann Emerg Med 1990; 19:1107-1112.
22. 2+. J Clin Invest 1992; 89:1988-1994.
23. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984; 108:188-193.
24. Del Castillo J, Engbaek L. The nature of the neuromuscular block produced by magnesium. J Physiol 1954; 124:370-384.
25. Altura BM, Altura BT. Magnesium ion and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc 1981; 40:2672-2679.
26. Sokordin MS, Freebeck PC, Yetter B, et al. Magnesium sulphate potentiates several cardiovascular and metabolic actions of terbutaline. Chest 1994; 105:701-705.
27. Cairns CB, Kraft M. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. Acad Emerg Med 1996; 3:1093-1097.
28. Emelyanov A, Fedoseev G, Barnes PJ. Reduced intracellular magnesium concentrations in asthmatic patients. Eur Respir J 1999; 13:38-40.
29. Alamoudi OSB. Hypomagnesaemia in chronic, stable asthmatics: prevalence, correlation with severity and hospitalization. Eur Respir J 2000; 16:427-431.
30. Dominguez LJ, Barbagallo M, Di Lorenzo G, et al. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. Clin Sci 1998; 95:137-142.
31. Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing and airway hyperreactivity in a random adult population sample. Lancet 1994; 344:357-362.
32. Fogarty A, Lewis S, Scrivener S, et al. Oral magnesium and vitamin C supplements in asthma: a parallel group randomised placebo-controlled trial. Clin Exp Allergy 2003; 33:1355-1359.
33. Fogarty A, Lewis SA, Scrivener SL, et al. Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial. Respir Med 2006; 100:174-179. This study showed no clinical benefit with magnesium supplementation, suggesting that the beneficial effects of magnesium therapy may be limited to the treatment of acute severe asthma.
34. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulphate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2006; 3:1-26. This meta-analysis shows that intravenous magnesium is safe and effective in patients with life-threatening attacks of asthma. The article, however, suggests that current evidence does not support the routine use of intravenous magnesium in all patients with severe asthma presenting to the emergency department.
35. Cheuk DKL, Chau TCH, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2006; 90:74-77. This meta-analysis concluded that, in children with severe exacerbations of asthma, intravenous magnesium results in significant bronchodilation and a marked reduction in requirement for hospital admission.
36. Blitz M, Blitz S, Beasley R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2006; 3:1-28. This meta-analysis concluded that nebulized inhaled magnesium in addition to salbutamol appears effective in the treatment of life-threatening attacks of asthma.
37. Rowe BH, Camargo CA. The use of magnesium sulphate in acute asthma: rapid uptake of evidence in North American emergency departments. J Allergy Clin Immunol 2006; 117:53-58. This audit identified that intravenous magnesium is widely used in the emergency department in the United States in the treatment of severe asthma. It also reported the emerging unregistered use of nebulized magnesium/salbutamol solution.